Affiliation:
1. Pulmonology Research Institute; А. I. Yevdokimov Moscow State University of Medicine and Dentistry of the Ministry of Health of the Russian Federation
2. А. I. Yevdokimov Moscow State University of Medicine and Dentistry of the Ministry of Health of the Russian Federation
3. А. I. Yevdokimov Moscow State University of Medicine and Dentistry of the Ministry of Health of the Russian Federation; JSC Medsi Group
4. JSC Medsi Group
Abstract
The aim of the work was to justify the algorithm of outpatient drug therapy in patients with COVID-19, based on the principle of «Multi-hit» Approach. The algorithm is based on the published results of clinical studies and observations, authors’ own practical experience in the use and management of more than 4 thousand patients diagnosed with COVID-19 of varying severity during the 2020 pandemic. The article substantiates a complex algorithm for the treatment of outpatients with COVID-19, which includes etiotropic, pathogenetic, and symptomatic components of therapy with different mechanisms of action. The described approach is the 1st stage (outpatient) of a complex algorithm for managing patients with COVID-19. It has been successfully implemented in the system of outpatient care for patients with novel coronavirus infections in several leading medical institutions in Russia. The authors believe that the developed algorithm for providing outpatient drug therapy for COVID-19, based on the principle of multiple exposure, may be useful in real clinical practice of managing patients with coronavirus infection.
Subject
Infectious Diseases,Microbiology (medical),General Medicine,Microbiology
Reference53 articles.
1. Otchet o tekushei situacii po bor’be s koronavirusom. Kommunikacionnii centr Pravitel’stva Rossiiskoi Federacii. 21.04.2021https://стопкоронавирус.рф (in Russian) ]
2. Temporary guidelines for the prevention, diagnosis and treatment of new coronavirus infection (COVID-19) of the Ministry of Health of the Russian Federation, version 10 (08.02.2021). Available at: https://static-0.minzdrav.gov.ru/system/attachments/attaches/000/054/662/original/Временные_МР_COVID-19_%28v.10%29.pdf (in Russian).)
3. Shi Y., Wang Y., Shao C., Huang J., Gan J., Huang X., Bucci E., Piacentini M., Ippolito G., Melino G. COVID-19 infection: the perspectives on immune responses. Cell Death Differ. 2020 May; 27 (5): 1451–1454. doi: 10.1038/s41418-020-0530-3. Epub 2020 Mar 23. PMID: 32205856; PMCID: PMC7091918.
4. Suhail S., Zajac J., Fossum C., Lowater H., McCracken C., Severson N., Laatsch B., Narkiewicz-Jodko A., Johnson B., Liebau J., Bhattacharyya S., Hati S. Role of oxidative stress on SARS-CoV (SARS) and SARS-CoV-2 (COVID-19) infection: a review. Protein J. 2020 Dec; 39 (6): 644–656. doi: 10.1007/s10930-020-09935-8. Epub 2020 Oct 26. PMID: 33106987; PMCID: PMC7587547.
5. Laforge M., Elbim C., Frère C., Hémadi M., Massaad C., Nuss P., Benoliel J.J., Becker C. Tissue damage from neutrophil-induced oxidative stress in COVID-19. Nat Rev Immunol. 2020 Sep; 20 (9): 515–516. doi: 10.1038/s41577-020-0407-1. Erratum in: Nat Rev Immunol. 2020 Aug 10;: PMID: 32728221; PMCID: PMC7388427.
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献